Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S has announced a significant share repurchase, acquiring 6,311,250 B shares from Novo Holdings A/S as part of a DKK 20 billion buyback program initiated in February 2024. The buyback, conducted at a weighted average market price following the company’s latest earnings release, slightly adjusts Novo Holdings A/S’s ownership stake in Novo Nordisk while aligning with its intent to maintain approximately 28% capital ownership. This strategic move reflects Novo Nordisk’s ongoing commitment to shareholder value and corporate governance.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
